Ajaya Kumar Paul

IPCA reported better-than-expected revenue growth of 15.8% driven by Domestic Formulation (DF) & exports. Company expects revenue growth of 9-10% with EBITDA margins of 22% in FY25. ▶️ Share this with your investing buddy. ☑️ Follow us for well-researched stock performance and key highlights. #Stocksfor2024 #IPCA #StockMarketIndia #StockMarketInvesting #FinancialSector #StockRecommendations #StockAnalysis #MarketAnalyis #MotilalOswal #Stocksfor2024 #IPCA #StockMarketIndia #StockMarketInvesting #FinancialSector #StockRecommendations #StockAnalysis #MarketAnalyis #MotilalOswal

Motilal Oswal Discover: IPCA Laboratories - On course to revive earnings growth. Watch video - https://youtu.be/Gl5zrzrxyB8 #stockmarket #motilaloswal #research #recommendationss #Laboratories #robustgrowth #IPCA #marketshare #ReviewonIPCA #Sitagliptin #stockmarket #motilaloswal #research #recommendationss #Laboratories #robustgrowth #IPCA #marketshare #ReviewonIPCA #Sitagliptin